Host: |
HEK293 cells |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Recombinant-Human CADM3/IGSF4B-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications. |
Formulation: |
Lyophilized from a 0.2 Mu m filtered solution of 20mM PB, 150mM NaCl, pH 7.2. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CADM3 |
Gene ID: |
57863 |
Uniprot ID: |
CADM3_HUMAN |
Immunogen Region: |
Asn25-His330 |
Immunogen: |
Recombinant Human CADM3/IGSF4B Protein is produced by Mammalian expression system. The target protein is expressed with sequence (Asn25-His330) of human CADM3 (Accession #Q8N126) fused with a 6xHis tag at the C-terminus. |
Function | Involved in the cell-cell adhesion. Has both calcium-independent homophilic cell-cell adhesion activity and calcium-independent heterophilic cell-cell adhesion activity with IGSF4, NECTIN1 and NECTIN3. Interaction with EPB41L1 may regulate structure or function of cell-cell junctions. |
Protein Name | Cell Adhesion Molecule 3Brain Immunoglobulin ReceptorImmunoglobulin Superfamily Member 4bIgsf4bNectin-Like Protein 1Necl-1Synaptic Cell Adhesion Molecule 3Syncam3Tslc1-Like Protein 1Tsll1 |
Database Links | Reactome: R-HSA-418990Reactome: R-HSA-420597 |
Cellular Localisation | Cell MembraneSingle-Pass Type I Membrane ProteinCell Junction |
Alternative Protein Names | Cell Adhesion Molecule 3 proteinBrain Immunoglobulin Receptor proteinImmunoglobulin Superfamily Member 4b proteinIgsf4b proteinNectin-Like Protein 1 proteinNecl-1 proteinSynaptic Cell Adhesion Molecule 3 proteinSyncam3 proteinTslc1-Like Protein 1 proteinTsll1 proteinCADM3 proteinIGSF4B proteinNECL1 proteinSYNCAM3 proteinTSLL1 proteinUNQ225 proteinPRO258 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance